We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.
- Authors
Hicks CB; Cahn P; Cooper DA; Walmsley SL; Katlama C; Clotet B; Lazzarin A; Johnson MA; Neubacher D; Mayers D; Valdez H; RESIST (Randomized Evaluation of Strategic Intervention in Multi-Drug Resistant Patients with Tipranavir) Investigator Group; Hicks, Charles B; Cahn, Pedro; Cooper, David A; Walmsley, Sharon L; Katlama, Christine; Clotet, Bonaventura; Lazzarin, Adriano; Johnson, Margaret A
- Publication
Lancet, 2006, Vol 368, Issue 9534, p466
- ISSN
0140-6736
- Publication type
article
- DOI
10.1016/s0140-6736(06)69154-x